Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 3/2018

15.01.2018 | Glaucoma

MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery

verfasst von: Bettina Hohberger, Ulrich-Christoph Welge-Lüßen, Robert Lämmer

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Glaucoma, a common disease in the elderly population, is frequently coexistent with cataract. While the combination of filtration surgery and cataract surgery is a challenging topic with limited success, minimal invasive glaucoma surgery (MIGS), such as Xen Gel Stents, seems to provide promising results. The aim of this study was to investigate the complete and qualified therapeutic success of Xen Gel Stent implantation with (XenPhaco) and without cataract surgery.

Methods

One hundred and eleven open-angle glaucoma eyes underwent implantation of Xen45 Gel Stent (AqueSys, Inc.) with or without cataract operation. Complete therapeutic success was defined as target intraocular pressure (IOP) < 18 mmHg at any time point within 6 months of follow-up without local antiglaucomatous therapy or further surgical interventions. Qualified success was defined as target IOP <18 mmHg with additional 1–2 local antiglaucomatous eye drops. Failure included all cases with the necessity of at least three local antiglaucomatous eye drops or additional glaucoma surgery.

Results

Combined implantation of Xen Gel Stent with cataract surgery was performed in 30 eyes and stand-alone Xen Gel Stent implantation was performed in 81 eyes. A complete therapeutic success was achieved in 46.9% of single Xen Gel Stent implantation, whereas 53.3% was reached with combined XenPhaco. Qualified success was seen in 2.5% in the eyes of the single Xen Gel Stent implantation group and in 3.3% of the combined surgery group. Therapeutic failure rate was 49.4% in the stand-alone group vs 46.7% in the combined group. Data were not significantly different for group and subgroup analyses.

Conclusions

Complete and qualified therapeutic success is similar for the combination of Xen Gel Stent implantation with and without cataract surgery in open-angle glaucoma patients. MIGS using Xen Gel Stent can be recommended in situations if glaucoma surgery is indicated besides coexisting cataract.
Literatur
5.
Zurück zum Zitat Hohberger B, Monczak E, Mardin CY (2017) 26 years of the erlangen glaucoma registry: demographic and perimetric characteristics of patients through the ages. Klin Monatsbl Augenheilkd [Epub before print - article in German]. https://doi.org/10.1055/s-0043-112856 Hohberger B, Monczak E, Mardin CY (2017) 26 years of the erlangen glaucoma registry: demographic and perimetric characteristics of patients through the ages. Klin Monatsbl Augenheilkd [Epub before print - article in German]. https://​doi.​org/​10.​1055/​s-0043-112856
Metadaten
Titel
MIGS: therapeutic success of combined Xen Gel Stent implantation with cataract surgery
verfasst von
Bettina Hohberger
Ulrich-Christoph Welge-Lüßen
Robert Lämmer
Publikationsdatum
15.01.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 3/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3895-3

Weitere Artikel der Ausgabe 3/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 3/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.